Xiao Ding

644 total citations
16 papers, 424 citations indexed

About

Xiao Ding is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xiao Ding has authored 16 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Xiao Ding's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Xiao Ding is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Xiao Ding collaborates with scholars based in China, United States and Singapore. Xiao Ding's co-authors include Song Li, Weihua Zhang, Hui Yang, Lühua Wang, Haiyan Jing, Meng Jiang, Junqing Han, Sheng Wei, Xingwen Wang and Lipin Liu and has published in prestigious journals such as Cancer Research, Cell Host & Microbe and Molecular Cancer.

In The Last Decade

Xiao Ding

15 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiao Ding China	5	261	215	89	88	76	16	424
Pasi Pennanen Finland	13	205 0.8×	161 0.7×	119 1.3×	109 1.2×	76 1.0×	16	502
Qianwei Xing China	14	149 0.6×	281 1.3×	53 0.6×	169 1.9×	61 0.8×	32	483
Jianqing Lin China	10	115 0.4×	202 0.9×	47 0.5×	55 0.6×	72 0.9×	33	354
Elisa N.D. Palladino United States	10	134 0.5×	284 1.3×	120 1.3×	65 0.7×	76 1.0×	13	536
Lizhi Lv China	13	150 0.6×	235 1.1×	48 0.5×	75 0.9×	100 1.3×	42	487
Xingkang Jiang China	13	394 1.5×	424 2.0×	29 0.3×	213 2.4×	37 0.5×	23	640
Christie Kang United States	5	108 0.4×	249 1.2×	39 0.4×	157 1.8×	44 0.6×	8	430
Huzi Xu China	9	135 0.5×	278 1.3×	44 0.5×	170 1.9×	26 0.3×	16	473
Heta Merikallio Finland	13	73 0.3×	208 1.0×	32 0.4×	156 1.8×	83 1.1×	24	443

Countries citing papers authored by Xiao Ding

Since Specialization

Citations

This map shows the geographic impact of Xiao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Ding more than expected).

Fields of papers citing papers by Xiao Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Ding. The network helps show where Xiao Ding may publish in the future.

Co-authorship network of co-authors of Xiao Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Ding. A scholar is included among the top collaborators of Xiao Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Ding. Xiao Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Liu, Chuanfa, Xiao Ding, Yang Sun, et al.. (2025). Multi-cohort analysis reveals colorectal cancer tumor location-associated fecal microbiota and their clinical impact. Cell Host & Microbe. 33(4). 589–601.e3. 5 indexed citations

Chen, Ming, E Mingyan, Li Zhang, et al.. (2025). Clinical features and outcomes of unresectable locally advanced lung adenocarcinoma with uncommon EGFR mutations: a retrospective multi-center Chinese study. Translational Lung Cancer Research. 14(1). 96–106.

Li, Qiang, H. J. Yang, Xiaoying Wu, et al.. (2024). Comprehensive genomic and clinical analyses identify APOBEC mutational signatures as a brain metastasis risk factor in lung adenocarcinoma patients. Translational Oncology. 43. 101921–101921. 1 indexed citations

Zhu, W. J., Xiaoyu Ding, Xiaojing Chen, et al.. (2024). Abstract 412: Discovery and preclinical characterization of ISM9342A, a novel, potent, and orally bioavailable WRN inhibitor that suppresses MSI-H tumor growth. Cancer Research. 84(6_Supplement). 412–412. 1 indexed citations

Li, Q, Jinxin Liu, Jing Shang, et al.. (2024). Abstract 1656: ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong anti-tumor activity in preclinical models of Hippo pathway-dysregulated cancers. Cancer Research. 84(6_Supplement). 1656–1656. 3 indexed citations

Zhang, Yihong, et al.. (2023). Abstract 4989: Discovery and evaluation of ISM6466A, a novel covalent CDK12 inhibitor for the treatment of cancer. Cancer Research. 83(7_Supplement). 4989–4989. 1 indexed citations

Sun, Deheng, et al.. (2023). Abstract 1855: Targeting DGKA for immuno-oncology therapy: ISM4312A, a novel DGKA inhibitor with robust anti-tumor activity. Cancer Research. 83(7_Supplement). 1855–1855. 1 indexed citations

Bi, Nan, Hong Ge, Lin Zhang, et al.. (2021). OA02.06 PSM Analysis Results from REFRACT: A Multi-Center Cohort Study Investigating the Treatment Patterns in EGFR-Mutant Unresectable LA- NSCLC. Journal of Thoracic Oncology. 16(3). S105–S106. 1 indexed citations

Li, Qiang, et al.. (2020). Induction chemotherapy for unresectable Stage III non-small-cell lung cancer may improve survival of induction chemotherapy responders as predicted by elevated levels of carcinoembryonic antigen and cytokeratin fragment 19 and classification as stage N3 cancer. Journal of Cancer Research and Therapeutics. 16(2). 222–229. 3 indexed citations

10.

Ding, Xiao, Weihua Zhang, Song Li, & Hui Yang. (2019). The role of cholesterol metabolism in cancer.. PubMed. 9(2). 219–227. 245 indexed citations

11.

Jiang, Meng, Xiao Han, Haiyan Jing, et al.. (2018). Histologic transformation of non-small-cell lung cancer in brain metastases. International Journal of Clinical Oncology. 24(4). 375–384. 11 indexed citations

12.

Li, Hua, Liqun Wu, Tao Shou, et al.. (2018). Abstract 1369: Analysis of association between homologous recombination deficiency and tumor mutational burden in solid tumors. Cancer Research. 78(13_Supplement). 1369–1369. 3 indexed citations

13.

Wang, Jing, Shijiang Wang, Xiao Ding, et al.. (2018). High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer.. PubMed. 11(5). 2675–2682. 4 indexed citations

14.

Liu, Lipin, Nan Bi, Lihong Wu, et al.. (2017). MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma. Molecular Cancer. 16(1). 50–50. 78 indexed citations

15.

Ding, Xiao, Meng Jiang, Haiyan Jing, et al.. (2014). Analysis of serum levels of 15 trace elements in breast cancer patients in Shandong, China. Environmental Science and Pollution Research. 22(10). 7930–7935. 65 indexed citations

16.

Ding, Xiao, Junqing Han, & Sheng Wei. (2009). Associations between serum levels of trace elements and breast cancer.. Journal of Shandong University. 47(7). 96–98. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact